Introduction

You have spent years managing high myopia with contact lenses — dealing with chronic dryness, lens discomfort during long screen sessions, and the quiet frustration of a prescription too high for laser surgery to safely correct. If you have recently discovered that ICL surgery in Korea is not only available but delivered by surgeons with considerably higher case volumes than most US providers, at a total all-in cost that competes directly with US pricing, you are already asking exactly the right questions.

For professional women aged 32–44 with high myopia, astigmatism, and pre-existing dry eye, the path to permanent vision correction is not straightforward — because not every procedure is appropriate, not every clinic has the diagnostic capability to assess your full clinical picture, and not every international facility can provide the post-operative continuity that returning to New York or Chicago demands. The gap between what you need and what most providers offer is precisely where Jryn Eye Clinic's approach to ICL surgery is designed to operate.

By the end of this guide, you will understand whether EVO ICL or toric ICL is the appropriate procedure for your specific prescription and dry eye history, exactly what all-in ICL surgery in Korea costs compared to New York, Los Angeles, and Chicago, how Jryn Eye Clinic's 20+ years of ophthalmology expertise and comprehensive pre-operative diagnostics differentiate the clinical experience, and what happens to your post-operative care after you fly home — and how your US optometrist can manage your follow-up using Jryn's English-language records.

"As a board-certified ophthalmologist who has performed ICL implantation procedures for over 20 years, including complex toric ICL cases for patients with high myopia and astigmatism, Dr. Sang Youp Han and the Jryn Eye Clinic team provide expert guidance grounded in clinical evidence and real patient outcomes."

What Is ICL Surgery in Korea — and Why Are International Patients Choosing Seoul?

What Is an Implantable Collamer Lens — and How Does ICL Surgery Work?

An Implantable Collamer Lens, or ICL, is a small, soft biocompatible lens surgically implanted between the iris and your natural crystalline lens — the structure responsible for focusing light. Unlike glasses or contact lenses, the ICL sits permanently inside the eye, eliminating the daily management of external correction without touching or altering your cornea in any way.

The current generation device — the STAAR Surgical EVO ICL — incorporates a central port called the KS-AquaPORT, which allows the natural flow of aqueous humour through the lens. This design innovation eliminates the need for a pre-operative laser iridotomy, a minor but historically necessary preparatory step in earlier ICL generations. The EVO ICL received FDA approval in the United States in 2022, confirming its safety and efficacy by the highest regulatory standard available.

The procedure itself is elegantly straightforward. Under topical anaesthesia — eye drops, not general sedation — your surgeon makes a micro-incision of approximately 2.8mm at the edge of the cornea. The ICL is injected through this opening in a folded state, unfolds inside the anterior chamber, and is gently guided into position behind the iris. The incision is self-sealing and requires no sutures. Each eye takes approximately 20–30 minutes. You leave the operating room with functional vision and return for your first post-operative check the following morning.

The distinction from LASIK is fundamental: ICL surgery does not remove, reshape, or permanently alter any corneal tissue. Your natural cornea remains entirely intact. And critically — a point of considerable importance for patients weighing their options — the EVO ICL can be removed or replaced if necessary. Unlike any laser vision correction procedure, this is not an irreversible change to your eye's architecture.

What Is EVO ICL and Why Korea Leads in EVO ICL Outcomes

The EVO ICL represents the fifth generation of STAAR Surgical's implantable collamer lens technology and is currently the global gold standard for permanent vision correction in patients with high myopia who are not ideal candidates for corneal laser procedures. Its combination of reversibility, broad prescription coverage (up to –18.00 diopters of myopia), and absence of corneal tissue removal places it in a clinical category that LASIK and SMILE cannot occupy.

Korea's position in global EVO ICL adoption is not incidental. Korean eye clinics were among the earliest adopters of EVO ICL technology, and the cumulative case volumes of senior Korean surgeons significantly exceed those of most US ophthalmologists — many of whom only began offering EVO ICL following its 2022 FDA approval. This matters because ICL surgery is not a procedure where all surgeons are equivalent: vault calculation accuracy — the precise selection of the gap between the ICL and the natural crystalline lens — is directly correlated with the thoroughness of pre-operative measurements and the surgeon's experiential judgment. An incorrectly calculated vault is the primary source of ICL complications, and experience is the most powerful mitigant of that risk.

At Jryn Eye Clinic, Dr. Sang Youp Han brings more than 20 years of ICL implantation experience to every case, supported by a comprehensive pre-operative diagnostic suite that includes anterior chamber depth assessment, endothelial cell count via specular microscopy, and Pentacam 3D corneal imaging. This is not a routine clinical workup — it is a purpose-built diagnostic protocol designed to eliminate sizing uncertainty before the procedure begins.

EVO ICL vs. LASIK: Which Is Right for You?

The core distinction between ICL and LASIK is architectural: ICL is additive (a lens is added to the eye's optical system), while LASIK is subtractive (corneal tissue is permanently removed to reshape the eye's focusing surface). For many patients, both procedures can achieve excellent outcomes — but the clinical scenarios in which one is clearly preferable over the other are well-defined.

ICL is the preferred procedure when myopia exceeds –6.00 diopters, when corneal thickness is insufficient for safe laser ablation, when the patient has a pre-existing history of dry eye syndrome, or when the prescription falls outside the safe LASIK treatment zone. LASIK may remain appropriate for lower prescriptions (–1.00 to –6.00 diopters) in patients with adequate corneal thickness and no significant dry eye history.

For patients with pre-existing dry eye — a profile highly prevalent in professional women who have worn contact lenses daily for years — the dry eye advantage of ICL is clinically significant. LASIK creates a corneal flap that severs corneal nerves responsible for tear production regulation; SMILE extracts a lenticule through a different mechanism but still involves corneal nerve disruption. ICL implantation, by contrast, does not involve the corneal surface at all. Corneal nerve integrity is preserved entirely, and post-operative dry eye risk is substantially lower. For more detail on LASIK comparisons, see our LASIK in Korea vs USA comparison.

Feature	EVO ICL	LASIK	SMILE Pro
Corneal tissue removed	No	Yes	Yes
Reversible	Yes	No	No
Prescription range	Up to –18.00	Up to –10.00	Up to –10.00
Dry eye risk	Lowest	Higher	Lower than LASIK
Recovery to clear vision	24–48 hours	24–48 hours	24–72 hours
FDA approved	Yes (2022)	Yes	Yes (SMILE Pro 2024)

For a comprehensive comparison of SMILE Pro, see the SMILE Pro in Korea — complete patient guide.

Are You a Candidate for ICL Surgery? Understanding Eligibility at Jryn Eye Clinic

Standard EVO ICL Candidacy Criteria

EVO ICL candidacy is determined by a combination of prescription profile, ocular anatomy, and general health. The following parameters define the standard candidacy window, though Jryn evaluates each patient individually and some cases outside these boundaries may still be appropriate for assessment.

The ideal age range for EVO ICL implantation is 21 to 45 years, a window that reflects both the stabilisation of refractive error in early adulthood and the onset of natural lens changes in the mid-to-late 40s. Prescription eligibility spans myopia from –3.00 to –18.00 diopters and hyperopia up to +10.00 diopters. Prescription stability — defined as no change greater than 0.50 diopters in the 12 months preceding surgery — is an important prerequisite; Jryn's pre-operative assessment reviews prior prescription records to confirm this.

Two anatomical measurements are non-negotiable for safe ICL implantation. Anterior chamber depth — the distance between the back surface of the cornea and the front surface of the natural lens — must be a minimum of 2.8mm to accommodate the ICL safely. Endothelial cell count, measured by specular microscopy, must meet a minimum threshold; the endothelial cells lining the inner cornea do not regenerate, and adequate cell density is a critical safety parameter that many providers do not emphasise sufficiently in patient education.

Additional criteria include the absence of active keratoconus, no significant corneal scarring, and no uncontrolled autoimmune disease or systemic conditions affecting wound healing.

Parameter	Minimum Requirement	Notes
Age	21–45 years	Evaluated case-by-case outside this range
Myopia	–3.00 to –18.00 D	EVO ICL range
Hyperopia	Up to +10.00 D	Hyperopic ICL
Anterior chamber depth	≥ 2.8mm	Assessed by Pentacam
Endothelial cell count	Minimum threshold	Assessed by specular microscopy
Prescription stability	≤ 0.50 D change in 12 months	Prior records reviewed
Corneal health	No active keratoconus	Full corneal mapping performed

Toric ICL Korea — The Premium Solution for High Myopia with Astigmatism

For patients who have both myopia and astigmatism, standard EVO ICL corrects the myopic component but does not address the cylindrical refractive error that astigmatism introduces. Toric EVO ICL incorporates a cylindrical correction component built directly into the lens, correcting both conditions simultaneously in a single implantation procedure. If your astigmatism is approximately 0.75 diopters or greater and you are seeking the most precise uncorrected visual acuity outcome, toric ICL is the clinically appropriate choice.

For professional women who have managed their astigmatism with toric contact lenses and want an equivalent level of optical precision in a permanent implanted solution, toric EVO ICL provides exactly that — without the daily management burden of contact lens rotation, lens displacement, or end-of-day dryness that toric soft lenses so frequently produce.

Toric ICL implantation introduces one additional technical element beyond standard EVO ICL: rotational stability. The cylindrical correction built into the toric lens must be oriented precisely along the patient's astigmatic axis and remain stable in that position over time. STAAR Surgical's toric EVO ICL design incorporates specific stabilisation features to support this, but the accuracy of initial placement during implantation — and the surgeon's precision in aligning the lens to the pre-marked axis — is directly skill-dependent. This is an area where Dr. Han's extensive toric ICL case volume provides a meaningful clinical advantage.

Published clinical studies on toric EVO ICL report that the majority of patients achieve uncorrected distance visual acuity of 20/20 or better following implantation. Toric ICL carries a modest pricing premium over standard EVO ICL, which is detailed in the cost section below.

Female-Specific Clinical Considerations for ICL Surgery

For women in the 32–44 age range, several clinical considerations intersect with ICL candidacy assessment in ways that are rarely addressed by standard patient information resources — but that matter significantly to your clinical outcome and surgical timing.

Hormonal influence on corneal shape and refraction is real and measurable. Oestrogen and progesterone fluctuations — related to menstrual cycle phase, oral contraceptive use, pregnancy, or the early stages of perimenopause — can cause transient changes in corneal curvature and refractive error. These changes are typically subtle but sufficient to affect the precision of pre-operative measurements if not accounted for. Jryn's pre-operative protocol addresses this by timing measurements appropriately and reviewing multiple prescription data points before confirming the target correction.

Pregnancy planning requires specific discussion for patients considering ICL in their early-to-mid 30s. The recommended interval between ICL surgery and conception is a minimum of 3–6 months, allowing full post-operative stabilisation before the hormonal environment of pregnancy begins. Patients planning pregnancy within 6 months should discuss timing with both Jryn's surgical team and their OB-GYN. Importantly, pregnancy itself does not damage or displace the ICL — the lens is anatomically stable and is not affected by the physiological changes of gestation. For patients planning pregnancy in 12–18 months, ICL surgery now is entirely appropriate from a clinical standpoint.

Dry eye in professional women with Persona 2's profile — chronic contact lens wear, sustained screen time, air-conditioned office and home environments, and hormonal factors — creates a specific tear film deficiency pattern that is frequently more severe than standard dry eye scales suggest. ICL surgery preserves all corneal nerve integrity, making it the clinically preferable vision correction procedure for this patient group. Laser procedures that disrupt the corneal nerve plexus can meaningfully worsen pre-existing dry eye, sometimes persistently. Jryn's approach integrates dry eye assessment into the pre-operative diagnostic protocol, and the clinic's dedicated dry eye treatment program provides specialist management for patients whose tear film requires optimisation before surgery.

Patients in their early-to-mid 40s should be aware that early lens changes — the beginning of the presbyopic process — can cause mild prescription drift that is distinct from myopic instability. Jryn's comprehensive pre-operative examination includes assessment for any early lens opacity or accommodation changes that would influence procedure selection. If early lens changes are identified, the conversation about presbyopia correction options at Jryn becomes part of your surgical planning discussion.

ICL Surgery Seoul Cost — What US Patients Actually Pay All-In

What Is Included in Jryn's ICL Surgery Package

Jryn Eye Clinic's ICL surgery package is designed to be genuinely comprehensive — the pricing you are quoted is the pricing you pay, without hidden add-on fees for diagnostics, follow-up visits, or documentation that other providers charge separately.

The package includes the full pre-operative diagnostic assessment (Pentacam 3D imaging, anterior chamber depth measurement, endothelial cell count by specular microscopy, cycloplegic refraction, pupil dilation examination, and full anterior and posterior segment examination), a surgeon consultation with Dr. Sang Youp Han or Dr. Heo Joong Gu, and the ICL implantation procedure itself for both eyes — standard EVO ICL or toric EVO ICL, with the pricing tier difference noted below. Both post-operative visits during your Seoul stay (Day 1 and Day 3 checks) are included, as is the complete post-operative eye drop kit for your full first-month protocol. Before you leave Seoul, you receive a complete English-language medical records package and surgical report formatted for seamless handover to your US optometrist, plus WhatsApp follow-up coordination for 90 days post-return.

ICL Surgery Seoul Cost: A City-by-City All-In Comparison for US Patients

The cost comparison below reflects realistic all-in estimates for a patient travelling from each major US city for ICL surgery at Jryn, compared to equivalent-quality ICL surgery at a reputable US provider in the same city.

Cost Element	Seoul (Jryn)	New York	Los Angeles	Chicago
EVO ICL procedure (both eyes)	~$3,800–$4,500	~$5,500–$8,000	~$5,000–$7,500	~$5,000–$7,000
Toric EVO ICL premium	+$300–$500	+$500–$1,000	+$500–$800	+$400–$800
Pre-op diagnostic assessment	Included	$300–$600 extra	$300–$500 extra	$200–$500 extra
Post-op visits (3 months)	Included (Seoul) + remote	$300–$600	$250–$500	$250–$500
Round-trip airfare	$700–$1,200	N/A	N/A	N/A
6-night accommodation	$600–$1,200	N/A	N/A	N/A
Estimated all-in total	$5,400–$7,400	$6,100–$9,200	$5,550–$8,800	$5,450–$8,800

All figures are estimates as of 2025–2026. Individual cases vary. Contact Jryn for a personalised quote. See also the total cost breakdown for Seoul eye surgery for a broader procedure comparison.

What this comparison makes clear is that the financial case for Seoul is not built primarily on cost savings — it is built on equivalent or lower cost combined with higher surgeon case volume, more comprehensive diagnostic assessment, and the cultural experience of Seoul. For many US patients, the all-in Seoul cost is broadly comparable to what they would spend at a premium New York or Los Angeles provider, while receiving care from a surgeon whose EVO ICL case experience substantially exceeds what is available domestically.

Insurance, Payment, and the Free Pre-Screening Policy

One question that arises consistently from US patients is whether their health insurance provides any coverage for ICL surgery performed in Korea. The answer is straightforward: ICL surgery is classified as elective refractive surgery and is excluded from standard US health insurance plans regardless of where the procedure is performed. Whether you choose a New York ophthalmologist or Jryn Eye Clinic in Seoul, your insurance situation is identical. Korea introduces no additional insurance disadvantage.

Payment at Jryn is straightforward — major international credit cards are accepted, wire transfer is available, and a formal invoice is issued for your personal records. Jryn's consultation fee is applied toward the procedure cost if you proceed; patients who are assessed and found not to be candidates are not charged the full procedure fee.

Critically, Jryn offers a free preliminary pre-screening assessment for patients who have not yet booked travel. By submitting your current prescription and most recent optometry report via WhatsApp or email, you receive a preliminary candidacy assessment within 24–48 hours — including a recommendation for standard EVO ICL vs. toric ICL and an indicative all-in cost estimate. This eliminates the primary financial risk of the international patient experience: the possibility of travelling to Seoul and discovering you are not a candidate.

Safety, Complications, and What Happens If Something Goes Wrong

Understanding ICL Surgery Risks — An Honest Clinical Overview

For the eye surgery safety in Korea — full guide and the specific context of EVO ICL, the risk profile is among the most favourable of any intraocular surgical procedure available. That said, no surgical procedure carries zero risk, and Jryn's clinical philosophy is one of transparency rather than minimisation.

The known risks of EVO ICL implantation fall into several categories. Elevated intraocular pressure (IOP) in the early post-operative period is the most frequently managed complication — it is typically transient and responds well to topical pressure-lowering drops. Permanent IOP elevation is rare when vault sizing has been performed accurately. Anterior subcapsular cataract formation — a subtle opacity on the front surface of the natural crystalline lens — can occur if the ICL vault is too low, allowing lens-to-lens contact; this risk is directly mitigated by precise pre-operative sizing. Halos and starbursts around light sources at night are common in the first weeks after implantation and resolve in the majority of patients within 3–6 months as the visual cortex adapts to the new optical system. Infection (endophthalmitis) is extremely rare with modern sterile surgical technique, occurring at a rate of less than 0.01% in published literature.

The vault issue deserves emphasis because it is the central safety variable in ICL surgery. Vault refers to the gap between the posterior surface of the ICL and the anterior surface of the natural crystalline lens. If this gap is too narrow, lens-to-lens contact accelerates early cataract formation. If the vault is too high, aqueous drainage can be impaired, raising IOP. The precise calculation of vault — and its verification on Day 1 and Day 3 post-operatively — is the most critical quality control element in the entire ICL process. Ten-year outcome studies published in peer-reviewed journals confirm that EVO ICL demonstrates high safety and stability over the long term, with the lens remaining in stable position without degradation in the overwhelming majority of cases.

Jryn's Complication Management Protocol

Jryn's approach to complication management begins before surgery — with the diagnostic thoroughness that makes complications less likely — and extends through a structured post-repatriation protocol that ensures no patient loses access to clinical guidance when they return home. This represents the international patient post-operative care protocol in full practice.

Every patient undergoes IOP measurement and vault assessment at the Day 1 and Day 3 post-operative appointments, both of which are included in the surgery package. Any IOP elevation detected at Day 1 is managed immediately with topical medication, and the patient's status is confirmed before they leave Seoul. Before departure, Jryn provides the patient's US optometrist with a written 90-day follow-up protocol specifying exactly what to measure at each visit — Week 1 home rest check, 1-month comprehensive examination, and 3-month final assessment — with all parameters described in US-standard clinical format.

For the 90 days following return, a dedicated WhatsApp contact is available for post-operative patients. Any urgent concern is triaged within 2–4 hours during Korean business hours, and Dr. Han is available for direct clinical consultation via WhatsApp video for complex post-repatriation concerns. If a US optometrist has a concern about vault or IOP between visits, Jryn can review slit-lamp photographs and IOP readings remotely and provide a clinical recommendation to the treating US provider — a practical remote consultation model that most international clinics do not offer.

The reversibility of EVO ICL functions as a defined safety net that no laser procedure can match. If any post-operative outcome is sub-optimal in terms of vault position, the lens can be removed or exchanged — a solution pathway that exists only because the ICL, unlike LASIK, has not permanently altered your corneal architecture.

20+ Years of Expertise — What Experience Actually Means for Your Safety

The relationship between surgeon volume and ICL safety outcomes is well-documented in the peer-reviewed literature: surgeons performing higher annual ICL volumes consistently demonstrate superior sizing accuracy and lower vault complication rates. This is not a marketing claim — it is the clinical rationale for why Jryn's 600 annual surgeries and Dr. Han's 20+ year ICL implantation history represent a direct, quantifiable safety advantage for every patient who enters the operating room.

Dr. Han has managed ICL complication cases referred from other clinics — a specific indicator of the depth of clinical experience that goes beyond routine procedure volume. Surgeons who receive referred complication cases have necessarily encountered and resolved the full clinical spectrum of ICL outcomes, including the rare complex presentations that most high-volume surgeons may see only a handful of times in a career.

Korean regulatory oversight further contextualises the safety environment. Korean eye clinics operate under KFDA (Korean Food and Drug Administration) oversight — a regulatory framework comparable in rigour to US FDA standards. The STAAR Surgical EVO ICL lenses implanted at Jryn are identical to the US FDA-approved product: the same manufacturer, the same materials, the same manufacturing specifications.

ICL Surgery Recovery — What to Expect Day by Day in Seoul and After You Return Home

Your ICL Recovery Timeline in Seoul — Day by Day

ICL recovery is notably well-tolerated by most patients, and the timeline below is specifically designed for international patients planning a 7-day Seoul visit around their procedure.

Day 0 — Surgery Day: The procedure is performed under topical anaesthesia, with each eye taking 20–30 minutes. You rest in the clinic's recovery area for 1–2 hours while IOP is monitored. Vision is functional immediately but may be slightly hazy with some light sensitivity. You return to your accommodation with a companion or Jryn's clinic coordinator escort, wearing sunglasses outdoors. Artificial tears are applied every 1–2 hours. A light meal and early sleep are recommended.

Day 1 — First Post-Op Check: Your mandatory morning appointment at Jryn measures IOP, assesses vault position, and tests visual acuity. Most patients report dramatically improved vision at this appointment — often clearer than their best corrected contact lens vision. Screen use is permitted in short intervals of 15–20 minutes with rest breaks.

Days 2–3 — Stabilisation: Vision continues to stabilise; light sensitivity reduces. Screen work up to 2–3 hours with regular breaks is permissible. Light walking and gentle indoor sightseeing are appropriate — avoid dusty or windy outdoor environments. No rubbing of eyes under any circumstances. Continue antibiotic and anti-inflammatory drops per your prescribed schedule.

Day 3 — Second Post-Op Check: Jryn confirms IOP stability and vault position at this appointment. The green light for extended screen use and return to normal office-level activities is typically given at this visit.

Days 4–6 — Functional Recovery: Most patients resume normal screen-based work remotely. Seoul sightseeing is appropriate with sunglasses; restaurants, cafes, and indoor cultural activities are fully permitted. Outdoor walking exercise is appropriate. No contact sports, swimming, or water activities.

Day 6–7 — Cleared to Fly: Safe to fly for most patients following the confirmed Day 3 check. Jryn provides a written flying clearance document and a complete in-flight eye drop protocol specifying frequency of artificial tear application during the long-haul flight home.

Activity	Restriction Period
Screen use (limited intervals)	Safe from Day 1
Full screen / office work	Safe from Day 3–4
Driving (daytime)	Safe from Day 3–5
Driving (night)	1–2 weeks (halos may persist)
Flying	Safe from Day 6–7 (post Day 3 check)
Light exercise / walking	Safe from Day 2
Gym / cardio	2 weeks post-surgery
Swimming / water sports	4 weeks post-surgery
Contact sports	4–6 weeks post-surgery
Eye makeup	2 weeks post-surgery

Managing Your Post-Operative Care Back in the US

The transition from Jryn's care to your US optometrist's care is not a handover into the unknown — it is a structured, documented, and supported process designed to ensure continuity across 14 time zones.

Before you leave Seoul, Jryn provides a complete English-language surgical report documenting the ICL model implanted, vault measurement at Day 1 and Day 3, IOP readings at both post-operative appointments, and any clinical observations relevant to your ongoing care. This is accompanied by a full post-operative instruction document formatted in US-standard clinical language, your 90-day WhatsApp follow-up schedule, and a referral letter addressed to your US optometrist.

The 1-month US check is specified in Jryn's post-op protocol document with exact parameters: uncorrected visual acuity, IOP measurement, slit-lamp anterior segment examination, and vault estimation. These are standard procedures for any qualified US eye doctor, and your optometrist does not need to have prior ICL experience to perform them — the protocol document specifies what to look for and what values to report back to Jryn.

The 3-month check serves as the final outcome assessment, confirming refractive stability and the long-term vault position. If you share your results via WhatsApp, Jryn reviews them remotely and provides a clinical response.

If you experience any concern between scheduled visits — unexpected visual disturbance, eye discomfort, redness, or anything that does not feel right — the protocol is simple: WhatsApp the Jryn post-operative care coordinator immediately, include a photograph of the eye and a description of your symptoms, and expect a response within 2–4 hours during Korean business hours. For urgent situations, emergency guidance is provided outside standard hours.

How to Plan Your ICL Surgery Trip to Seoul — A Practical Guide for US Patients

Getting to Seoul from Your US City

Seoul's Incheon International Airport (ICN) is one of the most consistently well-reviewed international airports in the world — efficient, English-friendly, and exceptionally well-connected to the US.

From New York (JFK/EWR), direct flights to Incheon take approximately 14–15 hours, operated by Korean Air, Asiana, and United. Round-trip economy fares typically range from $800–$1,200. From Los Angeles (LAX), the flight is approximately 11–12 hours direct on Korean Air, Asiana, or Delta, at $700–$1,100 round-trip. From Chicago (ORD), direct or one-stop routings via LAX or SEA take approximately 13–16 hours at $850–$1,300. From Houston (IAH), a one-stop connection via LAX or DFW totals approximately 16–18 hours at $900–$1,400. From Miami (MIA), routing via New York or LA totals approximately 18–22 hours at $950–$1,500.

The transit from Incheon to Jryn Eye Clinic in the Gangnam district is straightforward and inexpensive. The AREX express train from Incheon Airport to Hongik University station takes approximately 43 minutes, followed by Seoul Metro Line 2 to the Gangnam area in approximately 25 minutes — a total journey of 70–80 minutes at a cost of approximately $5–$8 USD. Airport limousine buses to Gangnam are also available for greater comfort at approximately $15–$20 USD with a 60–90 minute journey depending on traffic.

Accommodation, Safety, and What to Know as a Solo Female Traveller

Seoul is consistently ranked among the safest major cities in Asia for international visitors. The Gangnam district — where Jryn Eye Clinic is located — is a modern, internationally oriented urban neighbourhood with extensive English signage, a dense concentration of premium international hotels, and a hospitality sector well-accustomed to serving medical travellers. Kakao Maps and Google Maps both function reliably throughout the city, and navigation is straightforward even for first-time visitors.

Recommended accommodation for ICL surgery patients falls into several tiers. Premium options within close proximity to Jryn include the Grand InterContinental Seoul Parnas and the Park Hyatt Seoul. Mid-range options with excellent value and strong English-language service include the Glad Gangnam Coex Center and L7 Gangnam. Boutique and smaller hotel options are available on request from Jryn's patient coordinator, who can advise based on your specific dates and budget.

A companion is not medically required for ICL surgery, but is recommended for the surgery day to provide escort from the clinic to your hotel following the procedure. For solo patients without a companion, Jryn's patient coordinator can assist with clinic-to-hotel transport coordination on the surgery day — this is a standard service for international patients and eliminates the primary logistical concern for those travelling alone.

Your Suggested 7-Day Seoul Patient Itinerary

Day 1 (Arrival): Flight arrival at Incheon; transit to your Gangnam hotel by AREX and Metro or limousine bus; rest, hydration, and a light meal; review pre-operative instructions for tomorrow.

Day 2 (Pre-Op + Surgery): Morning pre-operative diagnostic assessment at Jryn (approximately 2–3 hours); afternoon ICL implantation procedure; escort to hotel; rest for the remainder of the day. Jryn's coordinator is available throughout.

Day 3 (Post-Op Day 1 Check): Morning post-operative appointment at Jryn; afternoon rest in hotel; evening — gentle restaurant dinner nearby.

Day 4 (Recovery + Light Sightseeing): Garosu-gil walking street in Gangnam; Apgujeong Rodeo Street; COEX Mall, which is ideal for light recovery activity given its indoor, air-conditioned environment and proximity to Jryn.

Day 5 (Extended Recovery Activities): Morning visit to Bukchon Hanok Village (light walking on relatively flat terrain); Insadong cultural district for galleries and Korean crafts; optional Korean skincare exploration in Myeongdong (명동).

Day 6 (Post-Op Day 3 Check + Final Clearance): Morning final Jryn check; receive discharge documentation, English-language surgical report, and flying clearance letter; afternoon leisure at your own pace.

Day 7 (Departure): Transfer to Incheon International Airport; flight home with your in-flight eye drop protocol in hand.

Why Choose Jryn Eye Clinic for ICL Surgery

Dr. Sang Youp Han's Expertise & Experience

Dr. Sang Youp Han is the Chief Director of Jryn Eye Clinic and a board-certified ophthalmologist with the Korean Board of Ophthalmology. His clinical career spans more than 20 years of comprehensive ophthalmology practice, with deep specialisation in SMILE LASIK, LASIK, standard and toric EVO ICL implantation, and cataract surgery. The clinic performs approximately 600 surgeries annually — a volume that places Jryn in the upper tier of Korean eye clinics by case frequency, which is itself the highest-volume ICL market in the world.

Dr. Han's specific ICL expertise extends beyond routine implantation. He has managed complex toric ICL cases requiring precise rotational stability, and has received ICL complication referrals from other clinics — the type of clinical experience that only develops when a surgeon has encountered, resolved, and learned from the full spectrum of outcomes that ICL surgery produces over a career of meaningful volume.

Dr. Han is supported by a specialist clinical team that reflects Jryn's commitment to comprehensive ophthalmology care. Dr. Heo Joong Gu brings extensive expertise in LASIK, LASEK, SMILE, and cataract treatment with oculoplastic surgery capability — ensuring that patients whose assessment reveals candidacy considerations beyond ICL are fully supported within the same clinic. Dr. Lee Jae Jung specialises in retinal diseases, macular degeneration, and complex retinal care, providing the in-house specialist coverage that ensures Persona 2 patients with dry eye or retinal concerns receive integrated, multi-specialist assessment in a single clinical environment.

Jryn's Diagnostic Excellence — Our Difference

The quality of an ICL outcome is a direct function of the quality of the pre-operative measurements — a principle that is consistently underemphasised in patient-facing communication across the industry. At Jryn, the pre-operative diagnostic protocol is not a formality; it is the primary determinant of outcome quality.

The protocol includes Pentacam 3D corneal imaging (providing comprehensive anterior segment mapping including corneal curvature, pachymetry, and anterior chamber depth in a single examination), endothelial cell count by specular microscopy, pupil diameter measurement under mesopic conditions, cycloplegic refraction to neutralise accommodative influence on the refractive measurement, and a full anterior and posterior segment examination by the operating surgeon. Every measurement that determines vault calculation accuracy is performed at Jryn before any surgical decision is made.

The clinic operates under KFDA regulatory oversight and uses STAAR Surgical EVO ICL lenses that are identical in specification to the US FDA-approved product. The 20+ year operating history of Jryn means that Dr. Han has accumulated the longitudinal clinical observation — across thousands of cases — that allows him to identify the subtle pre-operative presentations that predict challenging outcomes and address them proactively.

International Patient Support at Jryn Eye Clinic

Jryn's international patient support is delivered in English throughout the entire patient journey. A dedicated English-speaking patient coordinator manages pre-arrival communication, appointment scheduling, surgery-day clinic-to-hotel transport coordination for solo patients, and post-departure 90-day WhatsApp follow-up.

The clinic is reachable via WhatsApp during Korean business hours (9 AM – 6 PM KST), with email responses within 24 hours and a dedicated emergency post-operative contact line for active post-operative patients. International patient enquiries via WhatsApp are acknowledged within 2 hours during business hours. Pre-surgical communication — including the free preliminary candidacy assessment — can begin immediately, with no requirement to book travel before receiving a clinical response to your prescription profile.

How to Book Your ICL Surgery at Jryn Eye Clinic

Step 1 — Get Your Free Pre-Screening Assessment

Before you book any flights or commit to any dates, Jryn offers a free preliminary candidacy assessment based on your current prescription and optometry history. This virtual pre-screening eliminates the financial risk of international travel for a procedure you may not ultimately be a candidate for — and provides you with a preliminary recommendation for standard EVO ICL vs. toric ICL before any cost is incurred.

To receive your assessment, submit your current prescription for both eyes, your most recent US optometry or ophthalmology report if available, and a brief description of your dry eye history and contact lens wearing history. Jryn will return a preliminary candidacy assessment within 24–48 hours, including an indicative all-in cost estimate and the name of the surgeon most likely to manage your case. Submit via WhatsApp or email — details below.

Step 2 — Your Consultation and Surgery Planning

Once your preliminary candidacy is confirmed, Jryn schedules your in-person diagnostic assessment and surgery on consecutive or same days depending on scheduling availability. You receive a detailed pre-operative preparation guide covering the contact lens wearing cessation period (typically soft lenses 1 week prior to surgery, rigid gas permeable lenses 4 weeks prior), Seoul accommodation recommendations suited to your budget and proximity preferences, and a complete day-by-day patient itinerary for your 7-day visit. From the moment your dates are confirmed, your English-speaking coordinator is your single point of contact for every logistical and clinical question.

Schedule your consultation today via Inquiry form

Contact Jryn Eye Clinic

📞 Phone: +82517101004

💬 WhatsApp: Contact us via whatsapp

📧 Email: info@jryneyeclinic.com

🌐 Website: https://www.jryneyeclinic.com/

📍 Location: Busanjin-gu, Busan, Republic of Korea

🕘 Hours: Mon-Fri: 09:00 to 18:00, Sat: 09:00 to 13:00, Sun-PublicHolidays: Closed, LunchBreak: 12:30 to 14:00.

Frequently Asked Questions

Q1: Is EVO ICL Surgery Safe and What Is the Complication Rate?
A1: EVO ICL surgery has a strong long term safety profile, supported by 10 year outcome studies showing high stability and low complication rates. Serious complications such as infection occur in less than 0.01 percent of cases. Vault sizing accuracy is the main safety factor and is managed through detailed pre operative diagnostics and surgical experience.

Q2: How Is ICL Surgery Different from LASIK Which Is Better for High Myopia?
A2: ICL surgery is an additive procedure where a lens is implanted inside the eye, while LASIK is subtractive and removes corneal tissue. For myopia above minus 6.00 diopters, ICL is generally preferred because it preserves corneal structure, treats a wider range up to minus 18.00 diopters, and is reversible. LASIK remains suitable for lower prescriptions with adequate corneal thickness.

Q3: Can I Have ICL Surgery if I Have Chronic Dry Eyes?
A3: Yes, ICL surgery is often recommended for patients with chronic dry eye. Since the procedure does not involve the corneal surface, corneal nerves remain intact and the risk of post operative dryness is significantly lower than LASIK or SMILE. Pre operative dry eye assessment ensures the tear film is stable before surgery.

Q4: What Is Toric ICL and Do I Need It if I Have Astigmatism?
A4: Toric EVO ICL includes cylindrical correction to treat astigmatism along with myopia in one procedure. If astigmatism is around 0.75 diopters or higher, toric ICL is usually recommended to achieve optimal vision outcomes. It typically has a slightly higher cost than standard ICL.

Q5: How Long Does ICL Surgery Recovery Take Can I Return to Work in a Week?
A5: Most patients return to full time work within three to four days after surgery. For international patients, this allows remote work from Day 4 and travel home around Day 6 or 7. Normal professional activities can usually resume immediately after returning.

Q6: What Is the Total All In Cost of ICL Surgery in Korea vs the US?
A6: The total cost in Seoul including flights and accommodation from New York ranges from approximately 5400 to 7400 dollars. In comparison, similar procedures in the US range from about 6100 to 9200 dollars. The Seoul package often includes diagnostics, follow up visits, and remote care support.

Q7: How Does Jryn Eye Clinic Support Me After I Return to the US?
A7: Jryn provides a complete English language surgical report, a structured 90 day follow up plan, and direct communication through WhatsApp with a 2 to 4 hour response time. Remote consultations are available, and the clinic can review reports from your US provider if needed.

Q8: Will My US Health Insurance Cover ICL Surgery Done in Korea?
A8: No, ICL surgery is considered an elective procedure and is not covered by US health insurance, regardless of whether it is performed in Korea or the United States. The cost is typically out of pocket in both locations.

Q9: Is ICL Surgery Reversible if I Am Unhappy with the Result?
A9: Yes, EVO ICL is a reversible procedure. The implanted lens can be removed or replaced if needed. This is a key advantage compared to laser procedures, which permanently alter the cornea.

Q10: I Am Planning a Pregnancy in 12 to 18 Months Can I Still Have ICL Surgery Now?
A10: Yes, a 12 to 18 month gap is well within the recommended timeline. The minimum suggested interval before pregnancy is 3 to 6 months. The lens remains stable during pregnancy and is not affected by it.

Q11: How Do I Know the ICL Lens Used at Jryn Is the Same as in the US?
A11: Jryn uses STAAR Surgical EVO ICL lenses, which are the same FDA approved devices used in the United States. These lenses also meet Korean regulatory standards, ensuring equivalent quality and safety.

Q12: What Is the Minimum Number of Nights I Need to Stay in Seoul for ICL Surgery?
A12: A minimum stay of 6 to 7 nights is recommended. This includes time for pre operative assessment, surgery, recovery, and a Day 3 follow up check before travel clearance. Shorter stays are not advised as they limit proper monitoring.

Q13: Can My US Optometrist Manage My Follow Up Care Using Jryn Records?
A13: Yes, Jryn provides detailed English language records and a clear follow up protocol. Your optometrist can perform standard checks such as vision testing, eye pressure measurement, and slit lamp examination without requiring prior ICL experience.

Q14: How Do I Submit My Prescription for a Free Pre Screening Before Booking Travel?
A14: You can submit your prescription via WhatsApp or email along with your latest eye report and basic details about dry eye history and contact lens use. A preliminary assessment is typically provided within 24 to 48 hours at no cost.

Q15: What Is the Prescription Range That EVO ICL Can Correct?
A15: EVO ICL can correct myopia from minus 3.00 to minus 18.00 diopters and hyperopia up to plus 10.00 diopters. This makes it suitable for patients with high prescriptions who may not be eligible for laser based procedures.

Conclusion

ICL surgery in Korea at Jryn Eye Clinic offers a clinically superior alternative to laser vision correction for patients with high myopia, astigmatism, or pre-existing dry eye — combining the safety advantage of a cornea-preserving, reversible procedure with the expertise of a 20+ year ophthalmology team operating at the highest case volumes in the world's leading ICL market. The all-in cost of ICL surgery in Seoul — including flights and accommodation from New York, Los Angeles, or Chicago — is broadly comparable to or lower than equivalent-quality ICL at a premium US provider, with the added benefit of more thorough diagnostic assessment, higher surgeon case volume, and a clinical environment where EVO ICL is a deeply established, long-standing specialisation rather than a recently FDA-approved addition to the procedure menu.

Jryn's comprehensive post-repatriation care protocol, English-language medical records, and 90-day WhatsApp follow-up mean that your care does not end when your flight departs Seoul — it transitions to a structured, documented, and clinically supported continuation managed in collaboration with your US optometrist. Dr. Sang Youp Han's 20+ years of ICL implantation experience, combined with Jryn's diagnostic thoroughness and dedicated international patient support, means that every step of your journey — from your first WhatsApp message to your 3-month post-operative check with your New York optometrist — is planned, supported, and clinically managed.

The first step requires no travel, no commitment, and no cost: submit your current prescription and dry eye history to Jryn Eye Clinic via WhatsApp or email for a free preliminary candidacy assessment and receive a personalised response within 24–48 hours. If you are considering ICL surgery in Korea, contact Jryn Eye Clinic today and take the first step toward permanent, safe, and expertly managed vision correction.

About the Author

Dr. Sang Youp Han, MD — Board-Certified Ophthalmologist

Chief Director, Jryn Eye Clinic, Seoul, South Korea. Dr. Han brings 20+ years of clinical experience in ophthalmology, with specialisation in SMILE LASIK, LASIK, EVO ICL implantation (standard and toric), cataract surgery, and comprehensive vision correction for international patients. Board-certified by the Korean Board of Ophthalmology. The clinic performs 600+ surgeries annually, including complex toric ICL cases and complication management for cases referred from other clinics.

For consultations:

Phone: +82517101004
WhatsApp: Contact us via whatsapp
Email: info@jryneyeclinic.com